Search

everythinglearnresearchcommunity

for

Search:↓

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Green tea may help with health issues like cancer, heart disease, and weight loss due to its high catechin content.

The genus Sophora has compounds with potential health benefits and could lead to new drugs, but more research is needed to understand their effects and safety.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for male hypogonadism are effective and should be personalized.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Imiquimod 5% cream reduced equine sarcoids in most cases.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Neurosteroids show promise for treating epilepsy and more research is needed.

Some birth control pills have a higher risk of blood clots than others.

Biotin supplements are not proven to improve hair or nails and may interfere with medical tests.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Possible new treatments for common hair loss include drugs, stem cells, and improved transplants.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

New alopecia treatments aim for better results and fewer side effects.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.